Table 7

Change in outcomes between baseline and 8 weeks and baseline and 12 weeks

OutcomeBaseline (n=30)8 weeks (n=27)Change; 8 weeks—baseline (n=27)12 weeks (n=27)Change; 12 weeks—baseline (n=27)
Mean (SD)Mean (SD)Mean difference (95% CI); p valueMean (SD)Mean difference (95% CI); p value
ARAT* (0–57)15.9 (17.5)16.2 (17.3)0.17 (−0.86 to 1.21); 0.74318.2 (19.1)0.63 (−0.97 to 2.23); 0.440
FMA-UE (0–66)32.6 (16.4)35.2 (17.6)2.68 (0.86 to 4.49); 0.00434.4 (17.8)1.49 (−0.38 to 3.37); 0.118
SIPSO; total score (0–40)21.9 (9.3)23.5 (9.3)1.18 (−0.81 to 3.18); 0.24524.3 (8.1)2.17 (0.32 to 4.01); 0.021
MAL (0–5)0.89 (1.19)1.08 (1.16)0.19 (0.06 to 0.32); 0.0041.10 (1.19)0.13 (−0.02 to 0.28); 0.080
MMAS (0–5)2.0 (1.0)1.8 (1.0)−0.16 (−0.38 to 0.06); 0.1572.1 (1.1)0.08 (−0.19 to 0.35); 0.560
EuroQol-5D-5L; utility score0.49 (0.32)0.56 (0.30)0.07 (−0.009 to 0.142); 0.0880.54 (0.32)0.44 (−0.02 to 0.10); 0.145
Shoulder flexion†121.3 (18.2)123.8 (19.4)3.09 (−2.17 to 8.37); 0.249119.9 (21.2)−0.26 (−7.31 to 6.77); 0.940
Shoulder external rotation*†34.0 (19.9)41.5 (16.7)7.10 (2.36 to 11.84); 0.00340.6 (16.4)6.52 (0.02 to 13.03); 0.049
Shoulder abduction†107.6 (17.0)111.1 (19.3)3.21 (−2.00 to 8.42); 0.228108.7 (19.7)1.48 (−4.66 to 7.63); 0.636
Elbow flexion†142.3 (8.7)145.9 (5.6)3.28 (0.44 to 6.12); 0.024148.4 (6.3)6.00 (3.20 to 8.80); <0.001
Elbow extension†−4.26 (10.84)−4.14 (12.06)0.54 (−1.94 to 3.03); 0.669−4.29 (11.00)0.39 (−1.79 to 2.58); 0.724
Wrist extension†58.5 (29.1)67.1 (19.6)10.18 (1.31 to 19.05); 0.02467.81 (23.22)10.9 (1.8 to 20.1); 0.019
  • *n=26 at 12 weeks.

  • †Passive range of movement, degrees.

  • ARAT, Action Research Arm Test; FMA-UE, Fugl-Meyer Assessment–upper extremity; MAL, Motor Activity Log; MMAS, Modified Modified Ashworth Scale; SIPSO, Subjective Index of Physical and Social Outcome.